Novo owner commits $265 mln of Wegovy windfall to respiratory diseases

The Novo Nordisk Foundation, which controls drug maker Novo Nordisk (NOVOb.CO), said on Monday it would commit up to 1.8 billion Danish crowns ($265 million) to setting up an initiative aimed at improving vaccines for respiratory diseases.